Results 61 to 70 of about 13,001 (157)

From the microbiome to the central nervous system, an update on the epidemiology and pathogenesis of bacterial meningitis in childhood [version 1; referees: 3 approved] [PDF]

, 2017
In the past century, advances in antibiotics and vaccination have dramatically altered the incidence and clinical outcomes of bacterial meningitis. We review the shifting epidemiology of meningitis in children, including after the implementation of ...
Janowski, Andrew B, Newland, Jason G
core   +3 more sources

An Economic Evaluation of Direct Oral Penicillin Challenge for De‐Labelling Low Risk Patients With a Penicillin Allergy Label

Clinical &Experimental Allergy, Volume 55, Issue 5, Page 378-390, May 2025.
The cost of the Direct Oral Penicillin Challenge (DPC) itself is only a fraction of the full costs required to test for a penicillin allergy label by non‐allergists. The costs of DPC varied between hospitals using a nurse‐led, pharmacist‐led, or mixture of pharmacists and nurses.
R. Bestwick, R. Bhogal, K. Kildonaviciute, B. Y. Ng, B. Jackson, C. Moriarty, C. Thomas, L. Savic, S. A. Misbah, M. T. Krishna, R. Mujica‐Mota   +10 more
wiley   +1 more source

A rare case of peripheral facial paralysis associated with meningococcal meningitis - case report [PDF]

Romanian Journal of Pediatrics
Introduction. Meningococcal meningitis is a severe form of bacterial meningitis caused by the bacterium Neisseria meningitidis (N. meningitidis). It is a medical emergency and requires prompt treatment to prevent severe complications or death. Peripheral
Nicoleta-Ana Tomsa, Cristina Oana Marginean, Monica Cucuiet, Lorena Elena Melit   +3 more
doaj   +1 more source

Development of Multi-Locus Variable Number Tandem Repeat Analysis for Outbreak Detection of Neisseria meningitidis [PDF]

, 2006
Neisseria meningitidis is a major cause of septicemia and meningitis worldwide. Traditional typing methods like pulsed-field gel electrophoresis (PFGE) for identifying outbreaks are subjective and time consuming.
Price, Alicia Anne
core  

Cost-effectiveness of different MRSA screening methods.

, 2002
We describe a model to examine the cost-effectiveness of various laboratory-screening approaches to detect methicillin-resistant Staphylococcus aureus (MRSA).
Cookson, B, Kibbler, C, Kunori, T, Roberts, JA, Stone, S   +4 more
core   +1 more source

Cocirculation of Hajj and non-Hajj strains among serogroup W meningococci in Italy, 2000 to 2016 [PDF]

, 2019
In Italy, B and C are the predominant serogroups among meningococci causing invasive diseases. Nevertheless, in the period from 2013 to 2016, an increase in serogroup W Neisseria meningitidis (MenW) was observed.
Arghittu M., Barbui A. M., Bernaschi P., Bisbano A., Chironna M., Ciammaruconi A., De Nittis R., Fazio C., Galanti I. A., Giammanco A., Isola P., Mencacci A., Neri A., Pagani E., Stefanelli P., Vacca P., Vocale C.   +16 more
core   +1 more source

Hydrocephalus and Cerebral Small Vessel Disease in an Adult With Meningococcal Meningitis and Dilated Cardiomyopathy: A Fatal Outcome

Clinical Case Reports, Volume 13, Issue 4, April 2025.
ABSTRACT Meningococcal meningitis can lead to serious neurological complications such as hydrocephalus directly and contribute to cerebral small vessel disease indirectly, especially in patients with pre‐existing conditions like dilated cardiomyopathy.
Yousif Mohamed, Ahmed Mohamed, Abubaker Elemam, Abubaker Babiker   +3 more
wiley   +1 more source

Iowa Health Focus, September 2004 [PDF]

, 2004
Monthly newsletter for the Iowa Department of Public ...

core  

Pharyngeal carriage of Neisseria species in the African meningitis belt. [PDF]

, 2016
OBJECTIVES: Neisseria meningitidis, together with the non-pathogenic Neisseria species (NPNs), are members of the complex microbiota of the human pharynx.
Ali, Oumer A, Aseffa, Abraham, Bennett, Julia S, Borrow, Ray, Bugri, Akalifa, Collard, Jean-Marc, Dano, Ibrahim D, Daugla, Doumagoum M, Diallo, Aldiouma, Diallo, Kanny, Dieng, Marietou, Gadzama, Galadima, Gamougam, Kadidja, Greenwood, Brian M, Issaka, Bassira, Maiden, Martin CJ, Manigart, Olivier, Mbainadji, Lodoum, Mihret, Adane, Nascimento, Maria, Omotara, Babatunji A, Osei, Isaac, Quaye, Stephen L, Rebbetts, Lisa S, Sambo, Zailani B, Sow, Samba O, Stuart, James M, Tamboura, Boubou, Timbine, Youssouf, Trotter, Caroline, Watkins, Eleanor R, Woukeu, Arouna   +31 more
core   +1 more source

Long‐Term Efficacy and Safety of Ravulizumab in Adults With Anti‐Acetylcholine Receptor Antibody‐Positive Generalized Myasthenia Gravis: Final Results From the Phase 3 CHAMPION MG Open‐Label Extension

European Journal of Neurology, Volume 32, Issue 4, April 2025.
Ravulizumab demonstrated clinically meaningful and durable efficacy and safety in adults with anti‐acetylcholine receptor antibody‐positive generalized myasthenia gravis in the CHAMPION MG open‐label extension (OLE) study. Improvements from baseline in MG‐ADL, QMG, and MG‐QOL15r total scores, and the NeuroQOL Fatigue subscale scores achieved in ...
Tuan H. Vu, Renato Mantegazza, Djillali Annane, Masahisa Katsuno, Andreas Meisel, Michael W. Nicolle, Vera Bril, Rasha Aguzzi, Glen Frick, James F. Howard Jr, the CHAMPION MG Study Group   +10 more
wiley   +1 more source